ArticleTranslational cancer research2026
Development and validation of a DYX1C1- and GNAI1-based nomogram for predicting relapse in HER2-positive breast cancer treated with trastuzumab.
Junjie Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.